InvestorsHub Logo

jimmy667

03/28/22 11:37 PM

#454937 RE: jimmy667 #454935

By the way number and persistentcy of the naysayers such as AF, Citron and legions of naysayer posters against Anavex Life Sciences has been second only to NWBO. As a seven year veteran of investing in the Anavex battle ground stock as well as long term GILD and the DNDN saga in 2008. One thing stands out. To be successful the low current price of the stocks one has conviction means only it might be a time to accumulate over a long period and not try to time events or the market. Buy when it looks cheap but use restraint not to go all in at once. Five year holding period is a minimum.

jesster64

03/28/22 11:46 PM

#454938 RE: jimmy667 #454935

$100 a share?!!! This company can't even get above a $1. I've seen recent companies granted phase 1 approval shoot up over $5. Makes you wonder that those in the know, professional market analysts, haven't jumped in on a possible 100x. Maybe its because they know something. And why spend 500K on a large table at ASCO? Only significant news posted on company website since last years ASCO is approval for sawston. Unless they are withholding info......
I know, I know...quiet period, virus, war in ukraine, supply issues, funding, magazines fault, trapping shorts, lawsuits etc etc...
so much for end of 1st quarter predictions. next..